Lancashire and South Cumbria
Formulary
Sub Chapters : 08 Malignant disease and immunosuppression
Back to Chapters
Alkylating drugs
Anthracyclines and other cytotoxic antibiotics
Anti-androgens
Anti-lymphocyte monoclonal antibodies
Antimetabolites
Antiproliferative immunosuppressants
Arsenic trioxide
BCG bladder instillation
Bevacizumab
Bortezomib
Breast cancer
Brentuximab vedotin
Cetuximab
Corticosteroids and other immunosuppressants
Cytotoxic drugs
Dacarbazine and Temozolomide
Drugs affecting the immune response
Drugs for cytotoxic-induced side-effects
Erlotinib
Glatiramer acetate
Gonadorelin analogues
Hydroxycarbamide
Immunosuppressant therapy
Interferon Alfa
Interferon beta
Ipilimumab
Natalizumab
Oestrogens
Other antineoplastic drugs
Other immunomodulating drugs
Platinum compounds
Procarbazine
Progestogens
Prostate cancer and gonadorelin analogues
Protein kinase inhibitors
Somatostatin analogues
Taxanes
Topoisomerase I inhibitors
Trabectedin
Trastuzumab
Tretinoin
Vinca alkaloids and etoposide
Key
Full Site
